RA Capital Management »

Ascendis Pharma AS shares owned by RA Capital Management

Quarter-by-quarter ownership of Ascendis Pharma AS (ASND) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Ascendis Pharma AS

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma AS held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma AS by RA Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.7B 10M 266.72

More positions owned by RA Capital Management

Ascendis Pharma A/s Common Stock (ASND)
Parabilis Medicines Common Stock
Rhythm Pharmaceuticals Common Stock (RYTM)
Vaxcyte Common Stock (PCVX)
Sionna Therapeutics Common Stock (SION)
Tyra Biosciences Common Stock (TYRA)
Edgewise Therapeutics Common Stock (EWTX)
Newamsterdam Pharma Co Nv Common Stock (NAMS)
Hemab Therapeutics Holdings Common Stock
Septerna Common Stock (SEPN)
Bicara Therapeutics Common Stock (BCAX)
Mineralys Therapeutics Common Stock (MLYS)
Gh Research Common Stock (GHRS)
Disc Medicine Common Stock (IRON)
Spyglass Pharma Common Stock (SGP)

View all positions for RA Capital Management

Top funds holding Ascendis Pharma AS

RA Capital Management
Westfield Capital Management Company
Jupiter Topco
Artisan Partners Limited Partnership
T. Rowe Price Associates
American Century Companies
Perceptive Advisors
Principal Financial Group
Goldman Sachs Group
Citadel Advisors
Alliancebernstein
Jpmorgan Chase & Co
Bank of New York Mellon
Jane Street
Pictet Asset Management Holding SA

View all funds holding Ascendis Pharma AS